MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
47.22
-0.30 (-0.63%)
At close: Jun 30, 2025, 4:00 PM
47.20
-0.02 (-0.04%)
After-hours: Jun 30, 2025, 4:04 PM EDT
MLTX Market Cap
MLTX has a market cap or net worth of $3.00 billion as of June 30, 2025. Its market cap has increased by 9.79% in one year.
Market Cap
3.00B
Enterprise Value
2.62B
1-Year Change
9.79%
Ranking
Category
Stock Price
$47.22
Market Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $3.00B, an increase of 83,201.51%. That is a compound annual growth rate of 636.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 3.02B | -11.67% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |